Karin Lauer

Title: The Innovative Contributions of Karin Lauer

Introduction

Karin Lauer is a notable inventor based in Holzkirchen, Germany. She has made significant contributions to the field of transdermal therapeutic systems, particularly in the administration of buprenorphine. Her work has implications for pain management and therapeutic delivery methods.

Latest Patents

Karin Lauer holds a patent for a transdermal therapeutic system comprising buprenorphine. This invention focuses on a method of manufacturing a transdermal therapeutic system (TTS) that allows for the effective transdermal administration of buprenorphine and its analogues. The TTS is specifically designed for analgesic purposes and includes a drug delivery composition that combines buprenorphine with an adhesive component made from a mixture of crosslinked and non-crosslinked acrylic polymers, along with a penetration enhancer that is a keto acid. This innovative approach enhances the efficacy of pain relief through transdermal delivery.

Career Highlights

Karin Lauer is associated with Hexal AG, a company known for its advancements in pharmaceuticals. Her work at Hexal AG has allowed her to focus on developing innovative solutions in drug delivery systems.

Collaborations

Karin collaborates with talented professionals such as Jens Fleschhut and Susanne Feinaeugle, contributing to a dynamic team that drives innovation in their field.

Conclusion

Karin Lauer's contributions to the development of transdermal therapeutic systems highlight her role as an influential inventor in the pharmaceutical industry. Her innovative work continues to pave the way for advancements in pain management and drug delivery methods.